Pharmaceuticals, Biotechnology and Life Sciences
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular…
– $13 million raised in 1H19 – – Norovirus bivalent vaccine Phase 1b clinical study underway with results expected in…
64% Q1 revenue growth and 650 bps gross margin improvement LEXINGTON, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis…
Topline results in the previously treated EGFR cohort (cohort 1) of the poziotinib ZENITH20 trial are expected in Q4 2019.…
DUBLIN–(BUSINESS WIRE)–The “Global Bone Cancer Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. Small and medium sized pharmaceutical…
Due to an increase in the incidence of medical ailments, the marketstudied is expected to grow over the forecast period.
Second Launch@Shares Competition Announced in Collaboration withMTTC/MALSI Conference and MassBio’s MassCONNECT Program
63% seek competitive advantage by adding digital features to products or offering new digital solutions BOSTON–(BUSINESS WIRE)–Digital know-how is decisive…
BioLegend Campus Inauguration Symposium focused on Cancer Immunotherapy features Nobel Laureate and World-Renowned Immunologists SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/biolegend?src=hash" target="_blank"gt;#biolegendlt;/agt;–BioLegend, leading…
DUBLIN–(BUSINESS WIRE)–The “Analytical Report for Healthcare Licensing with focus on Transplant” report has been added to ResearchAndMarkets.com’s offering. Transplantation gives…